Canada Markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.9700-0.0500 (-2.48%)
At close: 03:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.0200
Open2.1100
BidN/A x N/A
AskN/A x N/A
Day's Range1.9600 - 2.1100
52 Week Range1.5400 - 6.7900
Volume14,957
Avg. Volume4,586
Market Cap38.759M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-1.1230
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Simply Wall St.

    Analysts Expect Breakeven For Medexus Pharmaceuticals Inc. (TSE:MDP) Before Long

    With the business potentially at an important milestone, we thought we'd take a closer look at Medexus Pharmaceuticals...

  • Baystreet

    Stocks in play: Medexus Pharmaceuticals

    And medac, a strategic partner of Medexus, are pleased to announce that medac has resubmitted its New ...

  • GlobeNewswire

    Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA

    Additional data collection and analysis reconfirms confidence in New Drug Application for TreosulfanNDA resubmission date consistent with previously announced timelineFDA decision still expected within six months of resubmission TORONTO and CHICAGO, April 22, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) and medac, a strategic partner of Medexus, are pleased to announce that medac has resubmitted its New Drug Application for Treosulfan (NDA) with the U.S. F